Advanced Prostate Cancer Consensus Conference: APCCC

Your Patient Received ADT Plus Docetaxel for M1 Castration-Sensitive/Naive Disease: Now What? - Christopher Sweeney

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage

Castration Resistant Prostate Cancer: Where are the Questions? - Eleni Efstathiou

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage

Non-Controversial Topics in Prostate Cancer - William Oh

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage

Is There a Role for Treating the Primary in Patients with Metastatic Disease? - Axel Heidenreich

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage

Should AR-V7 Be Used As A Clnical Test? - Philip Kantoff

Details
Phillip Kantoff, MD provides his perspective on the role of AR-V7 as a clincial test. (Presentation in 10 minutes). Biography: Philip Kantoff, MD., is the Chair, Department of Medicine; The George J. Bosl Chair Memorial Sloan Kettering Cancer Center. He is a board-certified medical oncologist and researcher specializing in the treatment of genitourinary cancers. His lab focuses on understanding th...